📈 69% of S&P 500 stocks beating the index - a historic record! Pick the best ones with AI.See top stocks

BioDelivery Sciences International (BDSI) Gains But Lags Market: What You Should Know

Published 03/21/2019, 05:45 AM
Updated 07/09/2023, 06:31 AM
US500
-
DJI
-

BioDelivery Sciences International (BDSI) closed at $5.30 in the latest trading session, marking a +0.57% move from the prior day. The stock lagged the S&P 500's daily gain of 1.09%. At the same time, the Dow added 0.84%, and the tech-heavy Nasdaq gained 1.42%.

Coming into today, shares of the specialty pharmaceutical company had gained 10.71% in the past month. In that same time, the Medical sector gained 1.58%, while the S&P 500 gained 1.18%.

BDSI will be looking to display strength as it nears its next earnings release. The company is expected to report EPS of -$0.08, up 55.56% from the prior-year quarter. Our most recent consensus estimate is calling for quarterly revenue of $19.74 million, up 74.99% from the year-ago period.

BDSI's full-year Zacks Consensus Estimates are calling for earnings of -$0.20 per share and revenue of $92.58 million. These results would represent year-over-year changes of +72.6% and +66.39%, respectively.

It is also important to note the recent changes to analyst estimates for BDSI. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.

Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 11.36% higher. BDSI is holding a Zacks Rank of #3 (Hold) right now.

The Medical - Biomedical and Genetics industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 90, which puts it in the top 36% of all 250+ industries.

The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

You can find more information on all of these metrics, and much more, on Zacks.com.



BioDelivery Sciences International, Inc. (BDSI): Free Stock Analysis Report

Original post

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.